The challenge of technology transfer in the API
When it comes to optimizing your API strategy, technology transfer can mean different things to differentiate Technology transfer in those Active Pharmaceutical Material strategies. This can refer to the transfer of processes (together with documentation) between product development to pharmaceutical manufacturing, or it can also mean transfers between manufacturing locations - both internally and between different companies. Technology transfer in this way is an integral part of the API strategy, and is therefore an important element for a healthy drug development program.
Continuity of supply, whether for toxicological studies or clinical trials, requires an effective technology transfer mechanism, as well as ensuring that there are no adverse changes in safety, quality, product efficacy, and that the process complies with all the laws and regulations required. Therefore, technology transfers must be planned carefully and intelligently - failure to do so often affects the overall timeline and operational costs of the development program (if your API strategy is outsourced, you are responsible for ensuring your Contract Research Organization (CRO) is working by building a high-quality data package, like you would if you were developing at home).
Pharmaceutical Technology Transfer
Technology transfer began when the API was passed from the medical chemistry laboratory to the development and synthesis phase. Initially, the information provided by the laboratory team must be reviewed in the first step. This helps the development team to ensure a clear understanding of chemistry, including its capabilities, methods and analytics. There are considerations that need to be made at this point, because chemistry may not be strong enough to undergo improvement in terms of synthesis or development.
4 Main Items That Also Need To Be Challenged To Ensure Successful Technology Transfers
Test the packaging line
If a product is a new SKU to the location, it is important to carry out line trials, fill the product into the proposed bottle or lid.
stability Method
A method that indicates stability must already exist, allowing on-site transfer of the protocol signed by the client.
Cleaning validation
Cleaning validation needs to be assessed, specifications and batch records need to be written.
Health and Safety Review
A Health and Safety Review needs to be done to ensure the ability to handle products safely.
The exit process starts with determining the desired end result or the point where the process can be considered successful and complete. Map of the process needed to achieve the following, technology transfer is only defined as being completed after the process operates in a reliable manner within the specified specifications. If you use third parties to develop your API program, they adopt a collaborative approach to work with you to ensure the process developed meets the requirements of your program.
A detailed strategy document must be developed that covers all the shortcomings identified, how to overcome these deficiencies and a description of the overall transfer strategy with steps for success. One of the most frequent obstacles to technology transfer is the transfer of knowledge. It is important that the team on the receiving side be equipped with the information, skills, expertise and technology needed.
The success of technology transfer depends on understanding the process at the recipient's site. This is best achieved by the development team and recipients who work together in a collaborative approach towards agreed upon final goals.
Process toughness is very important for the first time the right transfer that minimizes the impact on the supply chain. There are many benefits to your API strategy and drug development program to achieve technology transfer on time and within budget, including reduction in operational risk and compliance, higher product development to launch success rates and overall time faster to market, resulting in increased value company.
Basic Pharma life Science Private Limited is a Global Market Leader in the distribution of versatile chemicals connecting chemical manufacturers and end users to provide innovative business solutions. Chlorhexidine Intermediates, Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture a wide range of APIs and intermediates including many USFDA-certified products. Our Manufacturing to be its core competence and manufactures products under p-to-p agreement (private labelling) for an impressive list of customers. We have largest manufacturing capacity including intermediates.
Our Products
Intermediates of Chlorhexidine Base
Cetrimide CAS 1119-97-7 Manufacturer
When it comes to optimizing your API strategy, technology transfer can mean different things to differentiate Technology transfer in those Active Pharmaceutical Material strategies. This can refer to the transfer of processes (together with documentation) between product development to pharmaceutical manufacturing, or it can also mean transfers between manufacturing locations - both internally and between different companies. Technology transfer in this way is an integral part of the API strategy, and is therefore an important element for a healthy drug development program.
Continuity of supply, whether for toxicological studies or clinical trials, requires an effective technology transfer mechanism, as well as ensuring that there are no adverse changes in safety, quality, product efficacy, and that the process complies with all the laws and regulations required. Therefore, technology transfers must be planned carefully and intelligently - failure to do so often affects the overall timeline and operational costs of the development program (if your API strategy is outsourced, you are responsible for ensuring your Contract Research Organization (CRO) is working by building a high-quality data package, like you would if you were developing at home).
Pharmaceutical Technology Transfer
Technology transfer began when the API was passed from the medical chemistry laboratory to the development and synthesis phase. Initially, the information provided by the laboratory team must be reviewed in the first step. This helps the development team to ensure a clear understanding of chemistry, including its capabilities, methods and analytics. There are considerations that need to be made at this point, because chemistry may not be strong enough to undergo improvement in terms of synthesis or development.
4 Main Items That Also Need To Be Challenged To Ensure Successful Technology Transfers
Test the packaging line
If a product is a new SKU to the location, it is important to carry out line trials, fill the product into the proposed bottle or lid.
stability Method
A method that indicates stability must already exist, allowing on-site transfer of the protocol signed by the client.
Cleaning validation
Cleaning validation needs to be assessed, specifications and batch records need to be written.
Health and Safety Review
A Health and Safety Review needs to be done to ensure the ability to handle products safely.
The exit process starts with determining the desired end result or the point where the process can be considered successful and complete. Map of the process needed to achieve the following, technology transfer is only defined as being completed after the process operates in a reliable manner within the specified specifications. If you use third parties to develop your API program, they adopt a collaborative approach to work with you to ensure the process developed meets the requirements of your program.
A detailed strategy document must be developed that covers all the shortcomings identified, how to overcome these deficiencies and a description of the overall transfer strategy with steps for success. One of the most frequent obstacles to technology transfer is the transfer of knowledge. It is important that the team on the receiving side be equipped with the information, skills, expertise and technology needed.
The success of technology transfer depends on understanding the process at the recipient's site. This is best achieved by the development team and recipients who work together in a collaborative approach towards agreed upon final goals.
Process toughness is very important for the first time the right transfer that minimizes the impact on the supply chain. There are many benefits to your API strategy and drug development program to achieve technology transfer on time and within budget, including reduction in operational risk and compliance, higher product development to launch success rates and overall time faster to market, resulting in increased value company.
Basic Pharma life Science Private Limited is a Global Market Leader in the distribution of versatile chemicals connecting chemical manufacturers and end users to provide innovative business solutions. Chlorhexidine Intermediates, Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture a wide range of APIs and intermediates including many USFDA-certified products. Our Manufacturing to be its core competence and manufactures products under p-to-p agreement (private labelling) for an impressive list of customers. We have largest manufacturing capacity including intermediates.
Our Products
Intermediates of Chlorhexidine Base
Cetrimide CAS 1119-97-7 Manufacturer
